Like Ozempic, many of these medications may also help reduce the risk of weight-related health conditions, like heart disease
SURMOUNT-1 results (72 weeks, adults with obesity): 5 mg dose: approximately 15% body weight loss 10 mg dose: 19.5% body weight loss 15 mg dose: 22.5% body weight loss Placebo: 3.1% body weight loss At the 15 mg maximum dose, the average participant lost about 52 pounds over 72 weeks
Our experienced medical providers carefully evaluate each patients medical history, treatment goals, preferences, and potential side effects when recommending the most suitable GLP-1 receptor agonist
ADHD medications and risk of serious cardiovascular events in young and middle-aged adults
Two interventions have a strong evidence base and should, in my view, be part of every GLP-1 treatment discussion